ArticleOncogenesis2014

Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance.

L Truitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.